Last reviewed · How we verify
NCT05678829
Reproductive Health and Family Planning
NA trial testing Education in Virtual Reality in 130 participants. Status unknown.
30 April 2023
Quick facts
| Lead sponsor | Sümeyye Betül SÖNMEZ |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 130 |
| Start date | 15 July 2022 |
| Primary completion | 30 April 2023 |
| Estimated completion | 15 June 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Education
Conditions studied
- Virtual Reality — all drugs for Virtual Reality →
- Reproductive Health — all drugs for Reproductive Health →
Sponsor
Sümeyye Betül SÖNMEZ
Who can join
18 and older, female only, with Virtual Reality or Reproductive Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to measure the knowledge and attitude levels of women who play a key role in society on reproductive health and family planning, and to determine the changes in their attitudes and behaviors after face-to-face training with virtual reality application.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of Virtual Reality in Reproductive Health and Family Planning Education: A Randomized Controlled Trial: A Different Method In Reproductive Health And Family Planning Education: Virtual Reality.
Sönmez SB, Türkoğlu N. · · 2026 · PMID 41677032 · DOI 10.1111/phn.70082
Verify or expand the search:
- PubMed search for NCT05678829
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Education
Trials testing the same drug.
- NCT07521709 — Evaluation of an Online ACT and Compassion-based Intervention for Disorders of Gut-Brain Interaction · NA · not yet recruiting
- NCT07501988 — The Effect Of Color Rotation Technique Training On İnsülin Self-management İn Diabetic Patients. · NA · not yet recruiting
- NCT07142941 — Exercise and/or HMB in Older Diabetes With Low Muscle Mass · NA · not yet recruiting
- NCT07250568 — Office Program Effects on Pain, Posture, Muscle Physiology, Stress, Ergonomics, and Quality of Life in LBP Workers · NA · recruiting
- NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
Other recruiting trials for Virtual Reality
Currently open trials in the same condition.
- NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
- NCT07343843 — Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes Duri · NA · recruiting
- NCT07410858 — Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care · NA · recruiting
- NCT07021638 — EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health · NA · recruiting
- NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05678829 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sümeyye Betül SÖNMEZ
- Last refreshed: 12 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05678829.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing